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Abstract
Growing evidence supports the use of nephron-sparing techniques for the management of appropriately selected
renal masses up to 7 cm. Compared with the surgical standard of open partial nephrectomy, minimally invasive
approaches have demonstrated equivalent cancer control with reduced patient morbidity. Robot assistance has
the potential to provide patients and physicians greater access to minimally invasive nephron-sparing surgery.
We describe a robot-assisted retroperitoneal approach for the management of posterior renal masses. Our early
results suggest reduced perioperative morbidity with the ability to manage more complex tumors.
Introduction
Recent guidelines have emphasized the use of nephron-sparing approaches for the management of renal masses
up to 7 cm.1 Open partial nephrectomy is the historic stan-
dard for nephron-sparing surgery (NSS) with evidence to
support equivalent cancer control to radical nephrectomy in
appropriately selected tumors.2 While the retroperitoneal
approach reduces the possibility of intraperitoneal urine
leak, there is clear evidence that the flank incision is associ-
ated with significant morbidity compared with laparoscopic
approaches.3
Laparoscopic partial nephrectomy demonstrates equivalent
cancer control and improved convalescence compared with
open partial nephrectomy.4 Robot-assisted partial nephrec-
tomy may make minimally invasive NSS more accessible to
surgeons by facilitating intracorporeal suturing and knot tying.
Based on our experience with laparoscopic retroperitoneal
partial nephrectomy, we developed an approach to robot-
assisted retroperitoneal partial nephrectomy (RRPN) that
leverages the advantages of both a minimally invasive extra-
peritoneal approach and the robotic platform for intracorporeal
renorrhaphy. Others have described similar techniques. The
versatility of being able to perform a transperitoneal or retro-
peritoneal approach allows the surgeon to tailor the surgical
procedure to the tumor characteristics.
Technique
Patient selection
Based on previously published work,5 we select patients
with posterior tumors that were located in the interpolar area
or lower pole. For patients with upper-pole tumors, we favor
either a transperitoneal laparoscopic or robotic approach.
Although morbid obesity may obscure landmarks, is not a
contraindication for RRPN. In these patients, the flank posi-
tion and elevation of the kidney rest may aid in identification
of the tip of the 11th and 12th ribs, anterior superior iliac spine,
and costovertebral angle to aid in port placement. Patients
with previous intra-abdominal surgery are also well-suited
for this approach.
Patient positioning (Fig. 1)
Normal preoperative preparations are undertaken. Pa-
tients are placed in the full flank position on a beanbag with
the anterior superior iliac spine positioned over the ele-
vated kidney rest and the umbilicus positioned over the
break in the maximally flexed table. The anterior arm is
positioned on an armrest that is tilted toward the head as
much as possible. The patient is secured to the table with a
beanbag and cloth tape.
Initiation of the procedure (Fig. 2)
The patient is prepped and draped in the usual sterile
fashion. A 2-cm incision is made below the tip of the 12th rib
and extended through the fascia. The retroperitoneum is ac-
cessed with a tonsil clamp, and the space is bluntly dilated. It
is important to go through the thoracolumbar fascia or this
will need to be incised once the initial ports are placed to
visualize the kidney. A 12-mm balloon dilating trocar is pas-
sed and aimed posterior toward the ipsilateral shoulder and
inflated under direct vision using a 0-degree lens of a standard
laparoscope and camera to create the working space. The
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dilator is removed and replaced with a conventional 12-mm
trocar wrapped with petroleum gauze to avoid air leak. A
purse-string suture is placed around the skin to also aid in
reducing air leak. We switch to a conventional trocar because
we have found the robotic camera sticks to the valve in the
balloon dilator port, making it difficult to remove to clean if
needed.
An 8-mm robotic port is placed under direct vision at the
12th costovertebral angle. Using blunt dissection (generally
with a laparoscopic Kittner), the peritoneum is then swept
medially to create space for a medial 8-mm robotic trocar that
is placed two fingerbreadths below the level of the 11th rib.
Two assistant ports (5mm and 12mm) are placed on either
side of the anterior superior iliac spine. The table is angled 45
degrees, and the da Vinci robotic surgical system (Intuitive
Surgical, Sunnyvale, CA) is docked from the patient’s anterior
side approaching cephalad (Fig. 1). We have used both the S
and Si systemwithout difficulty but have not used the original
standard system for this procedure. We have not used the
third arm because of space limitations.
Identification of the hilum and tumor (video)
A 30-degree upward pointing lens is used for the proce-
dure. Depending on visualization, a 0-degree lens can be
used. We think, however, that the 30-degree upward pointing
lens positions the camera to allow the assistant more space to
work at the bedside, improving the ability to assist. Using the
robotic scissors and bipolar grasper, the hilum is identified in
line with the 8-mm costovertebral port. The artery and vein
are isolated to allow bulldog placement. We then incise the
Gerota fascia and dissect the mass free from its attachments to
FIG. 1. Patient positioning and room
setup.
FIG. 2. (A) Before robot docking; (B) after robot is docked.
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the surrounding perinephric fat, with the exception of a cap of
fat overlying the tumor. Intraoperative ultrasonography is
performed to identify the edges of the tumor as well as the
depth of penetration. The capsule surrounding the tumor is
scored with electrocautery.
Tumor resection and renorrhaphy (video)
Ten minutes before resection, we ask the anesthesiologists
to administer 12.5 g of mannitol. The hilum is clamped using
laparoscopic bulldog clamps. We prefer bulldogs over a Sa-
tinsky clamp because this avoids introducing an additional
port into a tight working space. In addition, the bulldog
eliminates the risk that the vascular clamp could be inadver-
tently bumped by the robotic or bedside surgeon. An ather-
mal technique is used to resect the tumor. The tumor is placed
in an endocatch bag, and a biopsy of the base is sent for frozen
section. The argon beam is used to coagulate the edges of the
resection. In a running fashion, 4-0 and 2-0 absorbable suture
is used to close the collecting system and the renal sinus, re-
spectively. Sewing can be expedited with the aid of absorb-
able suture clips (Lapra Ty clips, Ethicon Endo-surgery, Inc,
Cincinnati, OH) placed on the cut edge of the renal paren-
chyma or nonabsorbable suture clips when the suture is
placed through the capsule (Hem-o-lok clips, Teleflex Medi-
cal, Research Triangle Park, NC). Early unclamping can be
considered at this point.
Our routine is to place a rolled nitrocellulose bolster with
two preplaced 0-absorbable sutures on CT-1 needles, passed
inside-out of the resection bed through the capsule, secured in
place using Hem-o-lok clips, and tightened by sliding the clip
against the capsule.6 Additional premade 0-absorbable sutures
on a CT-1 needle with a Hem-o-lok secured at one end can be
used to further secure the bolster into place. We often use a
hemostatic agent and an additional sheet of nitrocellulose to
secure hemostasis. The bulldog clamps are then removed (if
not already done), and an additional 12.5 g of mannitol is
administered. The Gerota fascia can be reapproximated over
the defect using suture or clips. The insufflation pressure is
decreased to 5mm Hg to inspect for bleeding.
Procedure completion
The robot is undocked and a 30-degree conventional lapa-
roscope that was used at the beginning to create the retroper-
itoneal space is used to facilitate placement of a 10F rounddrain
in cases where the collecting system or sinus was entered. The
endocatch bag is removed through the camera port, extending
the incision as necessary to remove the tumor and overlying fat
intact. Depending on the size of the fascial defect, a Carter-
Thomason devicewith a 0-absorbable PGA suture or a running
0-absorbable PGA suture on a UR-6 needle can be used to close
this incision. The incisions are irrigated and the skin closed
with subcuticular suture. Dressings are placed, and the patient
is awoken and taken to the recovery room.
Post-operative care
The patient’s diet is advanced as tolerated. Antibiotics are
continued for 24 hours. Patients are encouraged to ambulate
the day after surgery. The bladder catheter is removed the
following morning and, if a drain has been left in place, it is
removed if the output remains low in the subsequent 4 hours.
The patient can then be discharged home. The patient is seen 2
weeks after surgery, and subsequent oncologic surveillance is
guided by pathologic results.
Table 1. Equipment
Procedure
initiation
Laparoscopic and
robotic instrumentation Hemostasis Closure
 20F Foley catheter
 Sequential
compression devices
 Orogastric tube
 12.5 gm intravenous
mannitol before and
after clamping kidney
 Arm rest for positioning
ipsilateral arm
 Beanbag for patient
positioning
 15 blade scalpel
 Bovie electrocautery
 0- and 30-degree
laparoscope (5- or
10-mm diameter)
 Insufflation
 Monitors
 Instruments: Kittner,
Maryland grasper,
suction-irrigator
 Laparoscopic ultrasound
 Laparoscopic bulldog
clamp
 Any existing version
of the robot
 Robotic instruments:
Monopolar scissors,
fenestrated bipolar,
needle drivers
 Nitrocellulose2 (one rolled
into premade bolster with
0-PGA suture on CT-1
needles preattached)
Clips and suture
 Surgical clips (Lapra Ty
and Hem-o-lok)
 2-0 absorbable PGA
suture on SH needle
cut to 8 inches
 4-0 absorbable PGA
suture on RB needle
cut to 8 inches
 0-absorbable PGA suture
on a CT-1 needle3-4 cut to
5 inches with a Hem-o-lok clip
secured to the end.
 Commercially available
hemostatic agent per
surgeon preference
 Argon beam coagulator
(or increase electrocautery
settings to coagulate
edges of resection bed)
 10F round drain
 2-0 nonabsorbable suture
to secure drain
 0 absorbable PGA suture to
close camera port using Carter-
Thomason device on a UR-6
needle in a running fashion
depending on size of defect
 4-0 absorbable monofilament
suture close skin incisions
Occlusive dressings
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Role of the bedside surgeon
The bedside surgeon is crucial in the successful completion
of the procedure. After the robot is docked into position, the
assistant aids in cephalad retraction with a laparoscopic Kitt-
ner and exposure of the hilum with the laparoscopic suction.
After adequate mobilization of the hilum, the assistant aids in
identifying the tumor by continued assistance with retraction.
To evaluate the full extent of the tumor, the assistant must be
comfortable in the use of laparoscopic ultrasound. The assis-
tant is also responsible for safely placing the bulldog clamps
preceding resection of the tumor and removing the clamps at
the completion of the resection and reconstruction. During
tumor resection and management of bleeding from the tumor
bed, the assistant must be confident in providing adequate
exposure and suction; replacing robotic instruments; placing
suture, bolster material, and hemostatic agents efficiently; and
cutting and removing suture. We have found it helpful to
discuss the anticipated steps in detail before clamping the
kidney and reviewing the success of the operation at the end of
the surgery to identify areas of quality improvement. While
these are the same roles as in the transperitoneal approach, the
smaller work space necessitates more intentional movements
by the assistant and better coordination.
Equipment
Table 1 describes the equipment used.
Role in Urologic Practice
From January 9, 2009 through June 21, 2010 we have
performed 16 RRPN. Table 2 summarizes the perioperative
results of our patients undergoing RRPN. This represents
the collective experience of four surgeons with experience in
laparoscopic, robot-assisted, and open partial nephrectomy.
We typically operated with two experienced surgeons early
in our experience. Nephrometry scores7 demonstrate that
most of these tumors were moderately complex with two
tumors abutting the renal hilum. All patients underwent
three-dimensional axial imaging within 3 months of sur-
gery. In the majority of cases, we clamped only the renal
artery. Postoperatively, a drain was placed in most patients
and was removed after the Foley catheter on the day of
discharge.
Figure 3 demonstrates the progressive decrease in opera-
tive time and ischemia time during the 18-month period. Two
conversions occurred: One to a transperitoneal robotic ap-
proach because of peritoneotomy and one to conventional
laparoscopy because of difficulty with positioning of the ro-
botic arms and camera during dissection of the tumor. A total
of six postoperative complications occurred. One patient
presented to the emergency department with pain, which,
after extensive evaluation with CT, laboratory studies, and
chest radiography, was found to be musculoskeletal and was
managed with oral pain medication. Pneumonia developed
in two patients; it was managed with oral antibiotics (one
patient was admitted to the hospital overnight). Urinary
retention developed in one patient; tamsulosin was initiated,
and the catheter was removed 1 week after surgery. Atrial
fibrillation developed postoperatively in one patient who had
a history of this condition; he was treated with diltiazem by
his cardiologist. Finally, one patient presented to clinic
1 week after the surgery with increasing flank pain. Renal
Table 2. Perioperative Outcomes
Variable (n¼ 16) Median (range)
Age (y) 57 (30–78)
Body mass index (kg=m2) 28 (26–46)
Tumor size (cm) 2.5 (1.1–3.5)
Operative time (min) 185 (160–300)
Ischemia time (min) 27.5 (15–52)
Estimated blood loss (mL) 100 (10–900)
Length of hospital stay (d) 2 (1–4)
Change in creatinine 0.1 (0–0.2)
Variable (n¼ 16) Strata N (%)
Sex Male
Female
12 (75)
4 (25)
Laterality Left
Right
9 (56)
7 (34)
Nephrometry score (all P) 6
7
8
9
2 (13)
9 (56)
4 (25)
1 (6)
Tumor location Interpolar
Lower
11 (69)
5 (31)
Tumor type Clear cell
Papillary
Chromophobe
Oncocytoma
10 (63)
3 (19)
2 (13)
1 (6)
Pathologic stage T1a
T3a
13 (87)
2 (13)
Surgical margin positive 0 (0)
Complication grade I
II
IIIb
1 (6%)
4 (25%)
1 (6%)
FIG. 3. Changes in operative parameters over time.
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ultrasonography demonstrated a 43 cm fluid collection ad-
jacent to the bolster that was managed with retrograde stent
placement in the operating room. This resolved, and the pa-
tient had the stent removed 3 weeks after surgery. There was
no postoperative hemorrhage necessitating blood transfusion,
and no episodes of acute renal failure.
The critical portion of this procedure is sufficient develop-
ment of the retroperitoneal space without entry into the
peritoneum and adequate port placement. Although a 5-mm
intraperitoneal trocar can be used to vent the peritoneum,
peritoneal violation increases the difficulty of the procedure,
necessitating cephalad retraction by the assistant. In addition,
poor port placement may make tumor dissection more chal-
lenging. If this occurs, conversion to a conventional laparo-
scopic approach may be necessary.
RRPN represents a useful technique in the armamentarium
of tools to manage small renal masses. This technique requires
comfort with the laparoscopic retroperitoneal and robotic
approaches. Early on, assistance of an experienced surgeon is
essential. Our initial data suggest that, in appropriately se-
lected patients, perioperative outcomes are excellent using
this technique.
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Weizer and colleagues describe a technique for ret-roperitoneal robot-assisted partial nephrectomy. The
technique, which is a derivation of the original technique
demonstrated by Dr. James Porter (Swedish Medical Cen-
ter, Seattle, WA) at numerous live surgeries in 2007 to 2010,
is demonstrated with clearly reproducible results. The pri-
mary advantage of the retroperitoneal approach is in the
approach to patients who have had multiple abdominal
surgeries and posterior tumors. Posterior tumors can be
more directly reached, but they can be easily reached
transperitoneally as well with renal mobilization. Never-
theless, the retroperitoneal approach offers the advantage
of a completely extraperitoneal procedure, which may have
benefits for recovery but would require an adequately
powered study to examine.
The authors rightfully comment on the benefit of experi-
enced assistance. The need for experienced assistance is true
for all robotic cases, and I am not sure it is unique to the
retroperitoneal approach. The same could easily be stated
for surgeons beginning their prostatectomy or cystectomy
experiences.
Most importantly, the cases become more challenging as
the amount of fat around the kidney is increased. Although
this is true of the transperitoneal approach as well, there may
Washington University School of Medicine, St. Louis, Missouri.
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